Fair enough...I guess CAN has a $450m+ market cap based on MM potential not yet realised, and QBL has a similar MM potential not yet realised...so the question for an investor is whether the market will rerate QBL to more closely resemble those of peers with similar value propositions.
In the meantime there is a hemp business building for QBL, which is something CAN does not have.
So bring me another $200m - $400m+ MM/cannabis/hemp stock on the ASX and let's compare again...I think you probably now have realised where this is going to go every time
cheers
- Forums
- ASX - By Stock
- CGB
- Ann: A World First for MCL in Autoimmune Disease Reasearch
Ann: A World First for MCL in Autoimmune Disease Reasearch, page-217
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)